RITA STUEDER: Open Payments
NPI 1952376709 · GREAT BEND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 45 payments from 9 companies in 2025. Trend: 2023 $677 · 2024 $1,022 · 2025 $684
Food & beverage: $594Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $202 |
| ABBVIE INC. | 12 | $165 |
| UCB, Inc. | 12 | $149 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: TREMFYA, Bimzelx, SKYRIZI, RINVOQ, COSENTYX, NEMLUVIO, OTEZLA, DUPIXENT.
Industry payments across KS — which companies pay providers there.
